Cargando…
一种新型中药配方通过触发磷酸戊糖途径依赖的氧化应激抑制非小细胞肺癌
Background and objective Non-small cell lung cancer (NSCLC) is one of the most lethal malignancies worldwide. A novel Chinese medicine formula-01 (NCHF-01) has shown significant clinical efficacy in the treatment of NSCLC, but the mechanism of this formula in the treatment of NSCLC is not fully unde...
Autores principales: | CHENG, Chuan, WU, Wei, YU, Jiaxin, YUAN, Dongdong, WANG, Yujiong, LI, Le |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial board of Chinese Journal of Lung Cancer
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600749/ https://www.ncbi.nlm.nih.gov/pubmed/37985150 http://dx.doi.org/10.3779/j.issn.1009-3419.2023.101.27 |
Ejemplares similares
-
Embelin通过氧化应激途径导致DNA损伤抑制HL-60细胞增殖
Publicado: (2015) -
依布替尼通过新型途径克服弥漫大B细胞淋巴瘤细胞耐药机制的研究
por: Sotomayor, E.
Publicado: (2017) -
人淋巴瘤细胞Jurkat通过Fas/FasL途径抑制人肺癌细胞A549的免疫逃逸
Publicado: (2010) -
西罗莫司联合钙调磷酸酶抑制剂治疗糖皮质激素耐药/依赖广泛型慢性移植物抗宿主病临床观察
Publicado: (2020) -
纵隔炎诊治应尽早外科干预
Publicado: (2018)